Intervention Review

Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer

  1. Philippe Lambin,
  2. Bram LT Ramaekers,
  3. Ghislaine APG van Mastrigt,
  4. P Van den Ende,
  5. J de Jong,
  6. Dirk K M De Ruysscher,
  7. Madelon Pijls-Johannesma*

Editorial Group: Cochrane Ear, Nose and Throat Disorders Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 23 FEB 2009

DOI: 10.1002/14651858.CD006158.pub2

How to Cite

Lambin P, Ramaekers BLT, van Mastrigt GAPG, Van den Ende P, de Jong J, De Ruysscher DKM, Pijls-Johannesma M. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD006158. DOI: 10.1002/14651858.CD006158.pub2.

Author Information

  1. GROW Research Institute, Department of Radiation Oncology (MAASTRO Clinic), Maastricht, Netherlands

*Madelon Pijls-Johannesma, Department of Radiation Oncology (MAASTRO Clinic), GROW Research Institute, University Medical Center, Maastricht, Netherlands. madelon.pijls@maastro.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2009

SEARCH

  1. Current Version

    Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer

    Philippe Lambin, Bram LT Ramaekers, Ghislaine APG van Mastrigt, P Van den Ende, J de Jong, Dirk K M De Ruysscher and Madelon Pijls-Johannesma

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD006158.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer

    Philippe Lambin, Madelon Pijls-Johannesma, J de Jong, P Van den Ende and Dirk K M De Ruysscher

    Article first published online: 15 APR 2009 | DOI: 10.1002/14651858.CD006158